Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07518004) titled 'ROME GS System Study: A Prospective, Multicenter Evaluation of Accuracy and Safety of the ROME GS System' on April 1.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Senseonics, Inc.
Condition:
Diabetes
Diabetes Melletus, Type 1
Diabetes Mellitus, Type 2
Intervention:
Device: Continuous Glucose Monitoring System
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: February 12, 2026
Target Sample Size: 60
Countries of Recruitment:
United States
To know more, v...